Geneos Wealth Management Inc. Brainstorm Cell Therapeutics Inc. Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.92 - $4.19 $29,492 - $42,319	-10,100 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$2.81 - $4.23 $28,381 - $42,723	10,100 New	10,100 $40,000
Q4 2020 May 19, 2021	SELL	$3.99 - $17.73 $399 - $1,773	-100 Closed	0 $0
Q3 2020 Sep 07, 2021	BUY	$11.19 - $16.92 $1,119 - $1,692	100 New	100 $1,000
Q2 2020 Sep 07, 2021	SELL	$4.42 - $12.66 $2,210 - $6,330	-500 Closed	0 $0
Q1 2020 Sep 07, 2021	BUY	$4.01 - $8.88 $2,005 - $4,440	500 New	500 $2,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.